P2RY12 and transient ischemic attack: The main analysis of PRINCE trial where platelet reactivity was assessed by VerifyNow P2Y12 assay in 675 patients with acute minor stroke or TIA has made a consistent conclusion with the TEG subgroup analysis [18]: ticagrelor was more efficacious than clopidogrel in inhibiting platelet reactivity.